Membership Overview
Paul McMahon: A Journey Through Imagination
March 28, 2017   

March is Brain Injury Awareness Month. Featured is a patient's personal experience, in his own words, of his traumatic brain injury (TBI) journey...
 Continue reading
Blood Biomarker May Help Predict Recovery Time for Sports Concussions
March 24, 2017   

Researchers discovered that the blood protein tau may be a potential objective tool to assess athlete recovery and the most appropriate time to return to play...
 Continue reading
Probiotic Found in Yogurt Can Reverse Depression Symptoms in Mice
March 17, 2017   

New research has shown that depressive symptoms and behaviors in mice were reversed when the mice were given food containing the probiotic bacteria lactobacillus...
 Continue reading (Members only)
Guidelines for the Recognition and Treatment of Depression with Mixed Features
March 10, 2017   

The Diagnostic and Statistical Manual of Mental Disorders 5th Edition (DSM-5) incorporated a "mixed features" specifier that recognizes the idea of mood disorders as lying on a spectrum and acknowledges the coexistence of subthreshold symptoms of (hypo)mania during a major depressive episode (or of subthreshold symptoms of depression co-occurring with a manic episode)...
 Continue reading
Consensus Statement on Use of Ketamine for Mood Disorders
March 9, 2017   

Based primarily on small-scale studies and numerous case reports, much excitement has been built around the use of ketamine in the treatment of mood disorder...
 Continue reading (Members only)
Brain Volume Differences in ADHD
March 3, 2017   

In a recent mega analysis study, researchers found that MRI scans showed that people diagnosed with attention deficit hyperactivity disorder (ADHD) have slightly smaller overall brain volume than people without ADHD...
 Continue reading (Members only)
Federal Court Overturns Florida "Gun-Gag" Law
February 20, 2017   

A federal court has overturned a 2011 Florida law that prohibited physicians from asking their patients about the presence of guns in the home unless it was medically necessary...
 Continue reading
Merck Ends Trial of Alzheimer’s Medication
February 17, 2017   

Merck and Co Inc recently announced that they will halt a late-stage trial of the drug, verubescestat, developed to treat mild to moderate Alzheimer’s disease...
 Continue reading (Members only)
To Sleep, Perchance to Learn
February 16, 2017   

Two recent studies in mice suggests that sleep may have much to do with preparing the brain for learning...
 Continue reading (Members only)
Randomized Controlled Trial Shows Potential Benefit of Dietary Improvement for Major Depression
February 13, 2017   

In a recent study, a 12-week adjunctive dietary intervention program called SMILES was tested for the treatment of moderate to severe depression in patients diagnosed with depression...
 Continue reading (Members only)
Top of Page